{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T05:08:53Z","timestamp":1770440933812,"version":"3.49.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,6]]},"DOI":"10.7759\/cureus.103096","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T14:40:17Z","timestamp":1770388817000},"source":"Crossref","is-referenced-by-count":0,"title":["Management of Retinopathy of Prematurity in the United Arab Emirates: A Consensus Statement From the Emirates Society of Ophthalmology"],"prefix":"10.7759","author":[{"given":"Abeer K","family":"Al Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noura","family":"Al Qassimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanan","family":"Al Shamsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Muhammad Asad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tulika","family":"Kar MS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laila","family":"Obaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Firdaus","family":"Sukhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan Salim","family":"Al Hasid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayesha","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Irfan Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darakhshanda","family":"Khurram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5409\/wjcp.v5.i1.35","article-title":"Retinopathy of prematurity: past, present and future","volume":"5","author":"Shah PK","year":"2016","unstructured":"Shah PK, Prabhu V, Karandikar SS, Ranjan R, Narendran V, Kalpana N. Retinopathy of prematurity: past, present and future. World J Clin Pediatr. 2016, 5:35-46. 10.5409\/wjcp.v5.i1.35","journal-title":"World J Clin Pediatr"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3345\/cep.2021.00773","article-title":"Retinopathy of prematurity: a review of epidemiology and current treatment strategies","volume":"65","author":"Hong EH","year":"2022","unstructured":"Hong EH, Shin YU, Cho H. Retinopathy of prematurity: a review of epidemiology and current treatment strategies. Clin Exp Pediatr. 2022, 65:115-26. 10.3345\/cep.2021.00773","journal-title":"Clin Exp Pediatr"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.earlhumdev.2007.11.009","article-title":"Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control","volume":"84","author":"Gilbert C","year":"2008","unstructured":"Gilbert C. Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. Early Hum Dev. 2008, 84:77-82. 10.1016\/j.earlhumdev.2007.11.009","journal-title":"Early Hum Dev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2014-305561","article-title":"Incidence and treatment of retinopathy of prematurity in England between 1990 and 2011: database study","volume":"99","author":"Painter SL","year":"2015","unstructured":"Painter SL, Wilkinson AR, Desai P, Goldacre MJ, Patel CK. Incidence and treatment of retinopathy of prematurity in England between 1990 and 2011: database study. Br J Ophthalmol. 2015, 99:807-11. 10.1136\/bjophthalmol-2014-305561","journal-title":"Br J Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2017-311789","article-title":"Incidence, risk factors and severity of retinopathy of prematurity in Turkey (TR-ROP study): a prospective, multicentre study in 69 neonatal intensive care units","volume":"102","author":"Bas AY","year":"2018","unstructured":"Bas AY, Demirel N, Koc E, Ulubas Isik D, Hirfanoglu \u0130M, Tunc T. Incidence, risk factors and severity of retinopathy of prematurity in Turkey (TR-ROP study): a prospective, multicentre study in 69 neonatal intensive care units. Br J Ophthalmol. 2018, 102:1711-6. 10.1136\/bjophthalmol-2017-311789","journal-title":"Br J Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4103\/sjopt.sjopt_18_22","article-title":"Pathophysiology of retinopathy of prematurity","volume":"36","author":"Strube YN","year":"2022","unstructured":"Strube YN, Wright KW. Pathophysiology of retinopathy of prematurity. Saudi J Ophthalmol. 2022, 36:239-42. 10.4103\/sjopt.sjopt_18_22","journal-title":"Saudi J Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2008.128","article-title":"UK retinopathy of prematurity guideline","volume":"23","author":"Wilkinson AR","year":"2009","unstructured":"Wilkinson AR, Haines L, Head K, Fielder AR. UK retinopathy of prematurity guideline. Eye (Lond). 2009, 23:2137-9. 10.1038\/eye.2008.128","journal-title":"Eye (Lond)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S401122","article-title":"Latest trends in retinopathy of prematurity: research on risk factors, diagnostic methods and therapies","volume":"16","author":"Bujoreanu Bezman L","year":"2023","unstructured":"Bujoreanu Bezman L, Tiutiuca C, Totolici G, et al.. Latest trends in retinopathy of prematurity: research on risk factors, diagnostic methods and therapies. Int J Gen Med. 2023, 16:937-49. 10.2147\/IJGM.S401122","journal-title":"Int J Gen Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.86.6.696","article-title":"Retinopathy of prematurity: recent advances in our understanding","volume":"86","author":"Wheatley CM","year":"2002","unstructured":"Wheatley CM, Dickinson JL, Mackey DA, Craig JE, Sale MM. Retinopathy of prematurity: recent advances in our understanding. Br J Ophthalmol. 2002, 86:696-700. 10.1136\/bjo.86.6.696","journal-title":"Br J Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.clp.2013.02.003","article-title":"The challenge of screening for retinopathy of prematurity","volume":"40","author":"Wilson CM","year":"2013","unstructured":"Wilson CM, Ells AL, Fielder AR. The challenge of screening for retinopathy of prematurity. Clin Perinatol. 2013, 40:241-59. 10.1016\/j.clp.2013.02.003","journal-title":"Clin Perinatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtumed.2019.05.001","article-title":"Perinatal risk factors for development of retinopathy of prematurity in a tertiary neonatal intensive care unit","volume":"14","author":"Nugud AA","year":"2019","unstructured":"Nugud AA, Nugud S, Nugud A, Nugud AA, Kathamuthu R, Jalal M. Perinatal risk factors for development of retinopathy of prematurity in a tertiary neonatal intensive care unit. J Taibah Univ Med Sci. 2019, 14:306-11. 10.1016\/j.jtumed.2019.05.001","journal-title":"J Taibah Univ Med Sci"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.2106\/00004623-200301000-00001","article-title":"Introducing levels of evidence to the journal","volume":"85","author":"Wright JG","year":"2003","unstructured":"Wright JG, Swiontkowski MF, Heckman JD. Introducing levels of evidence to the journal. J Bone Joint Surg Am. 2003, 85:1-3.","journal-title":"J Bone Joint Surg Am"},{"key":"ref13","unstructured":"Preterm birth. (2023). Accessed. September 14, 2025: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/preterm-birth."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/pr.2013.205","article-title":"Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010","volume":"74","author":"Blencowe H","year":"2013","unstructured":"Blencowe H, Lawn JE, Vazquez T, Fielder A, Gilbert C. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatr Res. 2013, 74:35-49. 10.1038\/pr.2013.205","journal-title":"Pediatr Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-1413","article-title":"The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study","volume":"116","author":"Good WV","year":"2005","unstructured":"Good WV, Hardy RJ, Dobson V, Palmer EA, Phelps DL, Quintos M, Tung B. The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study. Pediatrics. 2005, 116:15-23. 10.1542\/peds.2004-1413","journal-title":"Pediatrics"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2013.11.015","article-title":"Nationwide inventory of risk factors for retinopathy of prematurity in the Netherlands","volume":"164","author":"van Sorge AJ","year":"2014","unstructured":"van Sorge AJ, Termote JU, Kerkhoff FT, van Rijn LJ, Simonsz HJ, Peer PG, Schalij-Delfos NE. Nationwide inventory of risk factors for retinopathy of prematurity in the Netherlands. J Pediatr. 2014, 164:494-8. 10.1016\/j.jpeds.2013.11.015","journal-title":"J Pediatr"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.32007","article-title":"A review on the incidence and related risk factors of retinopathy of prematurity across various countries","volume":"14","author":"Nair A","year":"2022","unstructured":"Nair A, El Ballushi R, Anklesaria BZ, Kamali M, Talat M, Watts T. A review on the incidence and related risk factors of retinopathy of prematurity across various countries. Cureus. 2022, 14:e32007. 10.7759\/cureus.32007","journal-title":"Cureus"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4103\/0256-4947.87093","article-title":"Short-term outcome of very low-birth-weight infants in a tertiary care hospital in Saudi Arabia","volume":"31","author":"Al Hazzani F","year":"2011","unstructured":"Al Hazzani F, Al-Alaiyan S, Hassanein J, Khadawardi E. Short-term outcome of very low-birth-weight infants in a tertiary care hospital in Saudi Arabia. Ann Saudi Med. 2011, 31:581-5. 10.4103\/0256-4947.87093","journal-title":"Ann Saudi Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4103\/ojo.OJO_234_2014","article-title":"Retinopathy of prematurity: revisiting incidence and risk factors from Oman compared to other countries","volume":"10","author":"Reyes ZS","year":"2017","unstructured":"Reyes ZS, Al-Mulaabed SW, Bataclan F, et al.. Retinopathy of prematurity: revisiting incidence and risk factors from Oman compared to other countries. Oman J Ophthalmol. 2017, 10:26-32. 10.4103\/ojo.OJO_234_2014","journal-title":"Oman J Ophthalmol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.earlhumdev.2023.105844","article-title":"Risk factors in the development of retinopathy of prematurity: a 10-year retrospective study","volume":"185","author":"Di Pietro M","year":"2023","unstructured":"Di Pietro M, Decembrino N, Afflitto MG, et al.. Risk factors in the development of retinopathy of prematurity: a 10-year retrospective study. Early Hum Dev. 2023, 185:105844. 10.1016\/j.earlhumdev.2023.105844","journal-title":"Early Hum Dev"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-1180","article-title":"Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs","volume":"115","author":"Gilbert C","year":"2005","unstructured":"Gilbert C, Fielder A, Gordillo L, Quinn G, Semiglia R, Visintin P, Zin A. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics. 2005, 115:e518-25. 10.1542\/peds.2004-1180","journal-title":"Pediatrics"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(93)31665-9","article-title":"Prognostic factors in the natural course of retinopathy of prematurity. The cryotherapy for retinopathy of prematurity cooperative group","volume":"100","author":"Schaffer DB","year":"1993","unstructured":"Schaffer DB, Palmer EA, Plotsky DF, et al.. Prognostic factors in the natural course of retinopathy of prematurity. The cryotherapy for retinopathy of prematurity cooperative group. Ophthalmology. 1993, 100:230-7. 10.1016\/s0161-6420(93)31665-9","journal-title":"Ophthalmology"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3345\/kjp.2011.54.9.359","article-title":"Optimal oxygen saturation in premature infants","volume":"54","author":"Chang M","year":"2011","unstructured":"Chang M. Optimal oxygen saturation in premature infants. Korean J Pediatr. 2011, 54:359-62. 10.3345\/kjp.2011.54.9.359","journal-title":"Korean J Pediatr"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1590\/0034-7167-2018-0361","article-title":"Influence of oxygen in the development of retinopathy of prematurity","volume":"72","author":"Pastro J","year":"2019","unstructured":"Pastro J, Toso BR. Influence of oxygen in the development of retinopathy of prematurity. Rev Bras Enferm. 2019, 72:592-9. 10.1590\/0034-7167-2018-0361","journal-title":"Rev Bras Enferm"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1542\/peds.105.2.295","article-title":"Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial. I: Primary outcomes","volume":"105","author":"Phelps DL","year":"2000","unstructured":"Phelps DL. Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial. I: Primary outcomes. Pediatrics. 2000, 105:295-310. 10.1542\/peds.105.2.295","journal-title":"Pediatrics"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2018.04.002","article-title":"Retinopathy of prematurity: a review of risk factors and their clinical significance","volume":"63","author":"Kim SJ","year":"2018","unstructured":"Kim SJ, Port AD, Swan R, Campbell JP, Chan RV, Chiang MF. Retinopathy of prematurity: a review of risk factors and their clinical significance. Surv Ophthalmol. 2018, 63:618-37. 10.1016\/j.survophthal.2018.04.002","journal-title":"Surv Ophthalmol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1302298","article-title":"Oxygen saturation and outcomes in preterm infants","volume":"368","author":"Stenson BJ","year":"2013","unstructured":"Stenson BJ, Tarnow-Mordi WO, Darlow BA, et al.. Oxygen saturation and outcomes in preterm infants. N Engl J Med. 2013, 368:2094-104. 10.1056\/NEJMoa1302298","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.4103\/2249-4847.116403","article-title":"Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: the Canadian oxygen trial","volume":"2","author":"Al Hazzani F","year":"2013","unstructured":"Al Hazzani F, Khadawardi E. Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: the Canadian oxygen trial. J Clin Neonatol. 2013, 2:70-2. 10.4103\/2249-4847.116403","journal-title":"J Clin Neonatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0219934","article-title":"Risk factor analysis for the development and progression of retinopathy of prematurity","volume":"14","author":"Chang JW","year":"2019","unstructured":"Chang JW. Risk factor analysis for the development and progression of retinopathy of prematurity. PLoS One. 2019, 14:e0219934. 10.1371\/journal.pone.0219934","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2015-308221","article-title":"Preventing bioenergetic failure in the preterm infant","volume":"101","author":"Martin CR","year":"2016","unstructured":"Martin CR. Preventing bioenergetic failure in the preterm infant. Arch Dis Child Fetal Neonatal Ed. 2016, 101:F99-F101. 10.1136\/archdischild-2015-308221","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2016.98","article-title":"Systematic review and meta-analysis of human milk intake and retinopathy of prematurity: a significant update","volume":"36","author":"Bharwani SK","year":"2016","unstructured":"Bharwani SK, Green BF, Pezzullo JC, Bharwani SS, Bharwani SS, Dhanireddy R. Systematic review and meta-analysis of human milk intake and retinopathy of prematurity: a significant update. J Perinatol. 2016, 36:913-20. 10.1038\/jp.2016.98","journal-title":"J Perinatol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.siny.2013.01.006","article-title":"Nutrition, insulin-like growth factor-1 and retinopathy of prematurity","volume":"18","author":"H\u00e5rd AL","year":"2013","unstructured":"H\u00e5rd AL, Smith LE, Hellstr\u00f6m A. Nutrition, insulin-like growth factor-1 and retinopathy of prematurity. Semin Fetal Neonatal Med. 2013, 18:136-42. 10.1016\/j.siny.2013.01.006","journal-title":"Semin Fetal Neonatal Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.earlhumdev.2016.09.008","article-title":"IGF-1 in retinopathy of prematurity, a CNS neurovascular disease","volume":"102","author":"Liegl R","year":"2016","unstructured":"Liegl R, L\u00f6fqvist C, Hellstr\u00f6m A, Smith LE. IGF-1 in retinopathy of prematurity, a CNS neurovascular disease. Early Hum Dev. 2016, 102:13-9. 10.1016\/j.earlhumdev.2016.09.008","journal-title":"Early Hum Dev"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000002146","article-title":"The role of insulin-like growth factor-1 and its receptor in the eye: a review and implications for IGF-1R inhibition","volume":"39","author":"Truong T","year":"2023","unstructured":"Truong T, Silkiss RZ. The role of insulin-like growth factor-1 and its receptor in the eye: a review and implications for IGF-1R inhibition. Ophthalmic Plast Reconstr Surg. 2023, 39:4-12. 10.1097\/IOP.0000000000002146","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2018.01.016","article-title":"The genetics of retinopathy of prematurity: a model for neovascular retinal disease","volume":"2","author":"Swan R","year":"2018","unstructured":"Swan R, Kim SJ, Campbell JP, et al.. The genetics of retinopathy of prematurity: a model for neovascular retinal disease. Ophthalmol Retina. 2018, 2:949-62. 10.1016\/j.oret.2018.01.016","journal-title":"Ophthalmol Retina"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.clp.2013.02.002","article-title":"The biology of retinopathy of prematurity: how knowledge of pathogenesis guides treatment","volume":"40","author":"Smith LE","year":"2013","unstructured":"Smith LE, Hard AL, Hellstr\u00f6m A. The biology of retinopathy of prematurity: how knowledge of pathogenesis guides treatment. Clin Perinatol. 2013, 40:201-14. 10.1016\/j.clp.2013.02.002","journal-title":"Clin Perinatol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1080\/08820530902800314","article-title":"Retinopathy of prematurity: current concepts in molecular pathogenesis","volume":"24","author":"Heidary G","year":"2009","unstructured":"Heidary G, Vanderveen D, Smith LE. Retinopathy of prematurity: current concepts in molecular pathogenesis. Semin Ophthalmol. 2009, 24:77-81. 10.1080\/08820530902800314","journal-title":"Semin Ophthalmol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2014.07.050","article-title":"Pathophysiology and mechanisms of severe retinopathy of prematurity","volume":"122","author":"Hartnett ME","year":"2015","unstructured":"Hartnett ME. Pathophysiology and mechanisms of severe retinopathy of prematurity. Ophthalmology. 2015, 122:200-10. 10.1016\/j.ophtha.2014.07.050","journal-title":"Ophthalmology"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1111\/aos.12049","article-title":"The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge","volume":"92","author":"Cavallaro G","year":"2014","unstructured":"Cavallaro G, Filippi L, Bagnoli P, et al.. The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge. Acta Ophthalmol. 2014, 92:2-20. 10.1111\/aos.12049","journal-title":"Acta Ophthalmol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2021.05.031","article-title":"International classification of retinopathy of prematurity, third edition","volume":"128","author":"Chiang MF","year":"2021","unstructured":"Chiang MF, Quinn GE, Fielder AR, et al.. International classification of retinopathy of prematurity, third edition. Ophthalmology. 2021, 128:e51-68. 10.1016\/j.ophtha.2021.05.031","journal-title":"Ophthalmology"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-15-6552-6_4","article-title":"Diagnosis and classification of ROP","author":"Ells AL","year":"2021","unstructured":"Ells AL. Diagnosis and classification of ROP. A Quick Guide to Pediatric Retina. Wu WC, Lam, WC (ed): Springer, Singapore; 2021. 29-35. 10.1007\/978-981-15-6552-6_4"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.123.7.991","article-title":"The international classification of retinopathy of prematurity revisited","volume":"123","author":"International Committee for the Classification of Retinopathy of Prematurity","year":"2005","unstructured":"International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol. 2005, 123:991-9. 10.1001\/archopht.123.7.991","journal-title":"Arch Ophthalmol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-3810","article-title":"Screening examination of premature infants for retinopathy of prematurity","volume":"143","author":"Fierson WM","year":"2019","unstructured":"Fierson WM. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2019, 143:e20183810. 10.1542\/peds.2018-3810","journal-title":"Pediatrics"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2013.11.010","article-title":"Cardiopulmonary arrest following administration of Cyclomydril eyedrops for outpatient retinopathy of prematurity screening","volume":"18","author":"Lee JM","year":"2014","unstructured":"Lee JM, Kodsi SR, Gaffar MA, Rubin SE. Cardiopulmonary arrest following administration of Cyclomydril eyedrops for outpatient retinopathy of prematurity screening. J AAPOS. 2014, 18:183-4. 10.1016\/j.jaapos.2013.11.010","journal-title":"J AAPOS"},{"key":"ref45","article-title":"Preventing sight-threatening ROP: the role of nurses in reducing the risk","volume":"30","author":"Quiroga A","year":"2017","unstructured":"Quiroga A, Moxon S. Preventing sight-threatening ROP: the role of nurses in reducing the risk. Community Eye Health. 2017, 30:53-4.","journal-title":"Community Eye Health"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-12-132","article-title":"Pain and stress assessment after retinopathy of prematurity screening examination: indirect ophthalmoscopy versus digital retinal imaging","volume":"12","author":"Moral-Pumarega MT","year":"2012","unstructured":"Moral-Pumarega MT, Caser\u00edo-Carbonero S, De-La-Cruz-B\u00e9rtolo J, Tejada-Palacios P, Lora-Pablos D, Pall\u00e1s-Alonso CR. Pain and stress assessment after retinopathy of prematurity screening examination: indirect ophthalmoscopy versus digital retinal imaging. BMC Pediatr. 2012, 12:132. 10.1186\/1471-2431-12-132","journal-title":"BMC Pediatr"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.7196\/samj.6305","article-title":"Guideline for the prevention, screening and treatment of retinopathy of prematurity (ROP)","volume":"103","author":"Visser L","year":"2012","unstructured":"Visser L, Singh R, Young M, Lewis H, McKerrow N. Guideline for the prevention, screening and treatment of retinopathy of prematurity (ROP). S Afr Med J. 2012, 103:116-25. 10.7196\/samj.6305","journal-title":"S Afr Med J"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-3061","article-title":"Screening examination of premature infants for retinopathy of prematurity","volume":"142","author":"Fierson WM","year":"2018","unstructured":"Fierson WM. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2018, 142:3061. 10.1542\/peds.2018-3061","journal-title":"Pediatrics"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.earlhumdev.2023.105715","article-title":"UK screening and treatment of retinopathy of prematurity: updated 2022 guidelines","volume":"177","author":"Wilkinson AR","year":"2023","unstructured":"Wilkinson AR, Adams GG, Fleck BW, Nieto-Hernandez R. UK screening and treatment of retinopathy of prematurity: updated 2022 guidelines. Early Hum Dev. 2023, 177:105715. 10.1016\/j.earlhumdev.2023.105715","journal-title":"Early Hum Dev"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-018-0685-6","article-title":"Comparison of efficacy between anti-vascular endothelial growth factor (VEGF) and laser treatment in type-1 and threshold retinopathy of prematurity (ROP)","volume":"18","author":"Li Z","year":"2018","unstructured":"Li Z, Zhang Y, Liao Y, Zeng R, Zeng P, Lan Y. Comparison of efficacy between anti-vascular endothelial growth factor (VEGF) and laser treatment in type-1 and threshold retinopathy of prematurity (ROP). BMC Ophthalmol. 2018, 18:19. 10.1186\/s12886-018-0685-6","journal-title":"BMC Ophthalmol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1111\/aos.13549","article-title":"Increased frequency of retinopathy of prematurity over the last decade and significant regional differences","volume":"96","author":"Holmstr\u00f6m G","year":"2018","unstructured":"Holmstr\u00f6m G, Tornqvist K, Al-Hawasi A, Nilsson \u00c5, Wallin A, Hellstr\u00f6m A. Increased frequency of retinopathy of prematurity over the last decade and significant regional differences. Acta Ophthalmol. 2018, 96:142-8. 10.1111\/aos.13549","journal-title":"Acta Ophthalmol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2017-313574","article-title":"Incidence of retinopathy of prematurity (ROP) and ROP treatment in Switzerland 2006-2015: a population-based analysis","volume":"103","author":"Gerull R","year":"2018","unstructured":"Gerull R, Brauer V, Bassler D, et al.. Incidence of retinopathy of prematurity (ROP) and ROP treatment in Switzerland 2006-2015: a population-based analysis. Arch Dis Child Fetal Neonatal Ed. 2018, 103:F337-42. 10.1136\/archdischild-2017-313574","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjopt.2018.07.007","article-title":"Practical guidelines for screening and treatment of retinopathy of prematurity in Saudi Arabia","volume":"32","author":"Al Amro SA","year":"2018","unstructured":"Al Amro SA, Al Aql F, Al Hajar S, Al Dhibi H, Al Nemri A, Mousa A, Ahmad J. Practical guidelines for screening and treatment of retinopathy of prematurity in Saudi Arabia. Saudi J Ophthalmol. 2018, 32:222-6. 10.1016\/j.sjopt.2018.07.007","journal-title":"Saudi J Ophthalmol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(01)01015-6","article-title":"A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: Part 2. Refractive outcome","volume":"109","author":"Connolly BP","year":"2002","unstructured":"Connolly BP, Ng EYJ, McNamara JA, Regillo CD, Vander JF, Tasman W. A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: Part 2. Refractive outcome. Ophthalmology. 2002, 109:936-41. 10.1016\/S0161-6420(01)01015-6","journal-title":"Ophthalmology"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.18502\/jovr.v16i3.9437","article-title":"Aggressive posterior retinopathy of prematurity (APROP): LASER as the primary modality of treatment","volume":"16","author":"Narnaware SH","year":"2021","unstructured":"Narnaware SH, Bawankule PK, Raje D. Aggressive posterior retinopathy of prematurity (APROP): LASER as the primary modality of treatment. J Ophthalmic Vis Res. 2021, 16:400-7. 10.18502\/jovr.v16i3.9437","journal-title":"J Ophthalmic Vis Res"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2018.09.018","article-title":"Argon laser photocoagulation for macular edema in branch vein occlusion","volume":"196","author":"Clarkson JG","year":"2018","unstructured":"Clarkson JG, Gass JDM, Curtin VT, et al.. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol. 2018, 196:30-8. 10.1016\/j.ajo.2018.09.018","journal-title":"Am J Ophthalmol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(91)32247-4","article-title":"Laser photocoagulation for stage 3+ retinopathy of prematurity","volume":"98","author":"McNamara JA","year":"1991","unstructured":"McNamara JA, Tasman W, Brown GC, Federman JL. Laser photocoagulation for stage 3+ retinopathy of prematurity. Ophthalmology. 1991, 98:576-80. 10.1016\/S0161-6420(91)32247-4","journal-title":"Ophthalmology"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.5935\/0004-2749.20160029","article-title":"Treatment success of laser therapy for retinopathy of prematurity in referred and non-referred patients","volume":"79","author":"Kara C","year":"2016","unstructured":"Kara C, Petri\u00e7li \u0130S, Hekimo\u011flu E, Akil H, Beyazyildiz \u00d6. Treatment success of laser therapy for retinopathy of prematurity in referred and non-referred patients. Arq Bras Oftalmol. 2016, 79:96-9. 10.5935\/0004-2749.20160029","journal-title":"Arq Bras Oftalmol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.13005\/bpj\/839","article-title":"Studying the effect of tropicamide various concentrations on routine dilation of the pupil","volume":"8","author":"Shirzadi K","year":"2015","unstructured":"Shirzadi K, Amirdehi AR, Makateb A, Shahraki K, Khosravifard K. Studying the effect of tropicamide various concentrations on routine dilation of the pupil. Biomed Pharmacol J. 2015, 8:885-9. 10.13005\/bpj\/839","journal-title":"Biomed Pharmacol J"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.4103\/meajo.MEAJO_263_17","article-title":"Retinal detachment after cyclophotocoagulation in a child with Knobloch syndrome","volume":"25","author":"Al-Beshri AS","year":"2018","unstructured":"Al-Beshri AS, Kozak I, Craven ER. Retinal detachment after cyclophotocoagulation in a child with Knobloch syndrome. Middle East Afr J Ophthalmol. 2018, 25:161-2. 10.4103\/meajo.MEAJO_263_17","journal-title":"Middle East Afr J Ophthalmol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.71689","article-title":"Technical aspects of laser treatment for acute retinopathy of prematurity under topical anesthesia","volume":"58","author":"Jalali S","year":"2010","unstructured":"Jalali S, Azad R, Trehan HS, Dogra MR, Gopal L, Narendran V. Technical aspects of laser treatment for acute retinopathy of prematurity under topical anesthesia. Indian J Ophthalmol. 2010, 58:509-15. 10.4103\/0301-4738.71689","journal-title":"Indian J Ophthalmol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.3109\/08820538.2014.959198","article-title":"Side-effects and complications of laser treatment in diabetic retinal disease","volume":"29","author":"Deschler EK","year":"2014","unstructured":"Deschler EK, Sun JK, Silva PS. Side-effects and complications of laser treatment in diabetic retinal disease. Semin Ophthalmol. 2014, 29:290-300. 10.3109\/08820538.2014.959198","journal-title":"Semin Ophthalmol"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2012.302","article-title":"Posterior to the ridge laser treatment for severe stage 3 retinopathy of prematurity","volume":"27","author":"Ells AL","year":"2013","unstructured":"Ells AL, Gole GA, Lloyd Hildebrand P, Ingram A, Wilson CM, Geoff Williams R. Posterior to the ridge laser treatment for severe stage 3 retinopathy of prematurity. Eye (Lond). 2013, 27:525-30. 10.1038\/eye.2012.302","journal-title":"Eye (Lond)"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.2147\/EB.S189684","article-title":"Evidence to date: ranibizumab and its potential in the treatment of retinopathy of prematurity","volume":"11","author":"Patel SN","year":"2019","unstructured":"Patel SN, Klufas MA. Evidence to date: ranibizumab and its potential in the treatment of retinopathy of prematurity. Eye Brain. 2019, 11:25-35. 10.2147\/EB.S189684","journal-title":"Eye Brain"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-019-01088-7","article-title":"Assessment of vascular leakage and its development with FFA among patients treated with intravitreal anti-VEGF due to aggressive posterior ROP","volume":"39","author":"Ekinci DY","year":"2019","unstructured":"Ekinci DY, Vural AD, Bayramoglu SE, Onur IU, Hergunsel GO. Assessment of vascular leakage and its development with FFA among patients treated with intravitreal anti-VEGF due to aggressive posterior ROP. Int Ophthalmol. 2019, 39:2697-705. 10.1007\/s10792-019-01088-7","journal-title":"Int Ophthalmol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"Mintz-Hittner HA","year":"2011","unstructured":"Mintz-Hittner HA, Kennedy KA, Chuang AZ. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med. 2011, 364:603-15. 10.1056\/NEJMoa1007374","journal-title":"N Engl J Med"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2017.4838","article-title":"Comparing alternative ranibizumab dosages for safety and efficacy in retinopathy of prematurity: a randomized clinical trial","volume":"172","author":"Stahl A","year":"2018","unstructured":"Stahl A, Krohne TU, Eter N, et al.. Comparing alternative ranibizumab dosages for safety and efficacy in retinopathy of prematurity: a randomized clinical trial. JAMA Pediatr. 2018, 172:278-86. 10.1001\/jamapediatrics.2017.4838","journal-title":"JAMA Pediatr"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31344-3","article-title":"Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial","volume":"394","author":"Stahl A","year":"2019","unstructured":"Stahl A, Lepore D, Fielder A, et al.. Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial. Lancet. 2019, 394:1551-9. 10.1016\/S0140-6736(19)31344-3","journal-title":"Lancet"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1590\/S1984-82502011000100006","article-title":"Critical evaluation of the off-label indication and of the risks associated to the use of multi-dose vials on the treatment of age-related macular degeneration","volume":"50","author":"Barbosa BRD","year":"2014","unstructured":"Barbosa BRD, Barbosa SF, Tavares GD, Chacra NAB, Pinto T de JA. Critical evaluation of the off-label indication and of the risks associated to the use of multi-dose vials on the treatment of age-related macular degeneration. Brazilian J Pharm Sci. 2014, 50:63-72. 10.1590\/S1984-82502011000100006","journal-title":"Brazilian J Pharm Sci"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8567912","article-title":"Current evidence for the prevention of endophthalmitis in anti-VEGF intravitreal injections","volume":"2018","author":"Lau PE","year":"2018","unstructured":"Lau PE, Jenkins KS, Layton CJ. Current evidence for the prevention of endophthalmitis in anti-VEGF intravitreal injections. J Ophthalmol. 2018, 2018:8567912. 10.1155\/2018\/8567912","journal-title":"J Ophthalmol"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-018-0151-y","article-title":"Retinopathy of prematurity in the United Kingdom: retreatment rates, visual and structural 1-year outcomes","volume":"32","author":"Adams GG","year":"2018","unstructured":"Adams GG, Bunce C, Xing W, Butler L, Long V, Reddy A, Dahlmann-Noor AH. Retinopathy of prematurity in the United Kingdom: retreatment rates, visual and structural 1-year outcomes. Eye (Lond). 2018, 32:1752-9. 10.1038\/s41433-018-0151-y","journal-title":"Eye (Lond)"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.10.032","article-title":"Efficacy of primary intravitreal ranibizumab for retinopathy of prematurity in China","volume":"124","author":"Feng J","year":"2017","unstructured":"Feng J, Qian J, Jiang Y, et al.. Efficacy of primary intravitreal ranibizumab for retinopathy of prematurity in China. Ophthalmology. 2017, 124:408-9. 10.1016\/j.ophtha.2016.10.032","journal-title":"Ophthalmology"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.16-20680","article-title":"Recurrence of retinopathy of prematurity after intravitreal ranibizumab monotherapy: timing and risk factors","volume":"58","author":"Lyu J","year":"2017","unstructured":"Lyu J, Zhang Q, Chen CL, et al.. Recurrence of retinopathy of prematurity after intravitreal ranibizumab monotherapy: timing and risk factors. Invest Ophthalmol Vis Sci. 2017, 58:1719-25. 10.1167\/iovs.16-20680","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-018-4168-5","article-title":"Comparison of clinical outcomes of intravitreal ranibizumab and aflibercept treatment for retinopathy of prematurity","volume":"257","author":"Sukgen EA","year":"2019","unstructured":"Sukgen EA, Ko\u00e7luk Y. Comparison of clinical outcomes of intravitreal ranibizumab and aflibercept treatment for retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol. 2019, 257:49-55. 10.1007\/s00417-018-4168-5","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.124.1.24","article-title":"Outcome of eyes developing retinal detachment during the early treatment for retinopathy of prematurity study (ETROP)","volume":"124","author":"Repka MX","year":"2006","unstructured":"Repka MX, Tung B, Good WV, et al.. Outcome of eyes developing retinal detachment during the early treatment for retinopathy of prematurity study (ETROP). Arch Ophthalmol. 2006, 124:24-30. 10.1001\/archopht.124.1.24","journal-title":"Arch Ophthalmol"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001685","article-title":"Progressive retinal detachment in infants with retinopathy of prematurity treated with intravitreal bevacizumab or ranibizumab","volume":"38","author":"Yonekawa Y","year":"2018","unstructured":"Yonekawa Y, Wu WC, Nitulescu CE, et al.. Progressive retinal detachment in infants with retinopathy of prematurity treated with intravitreal bevacizumab or ranibizumab. Retina. 2018, 38:1079-83. 10.1097\/IAE.0000000000001685","journal-title":"Retina"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1097\/opx.0000000000000118","article-title":"Retina","volume":"90","author":"Alexander LJ","year":"2013","unstructured":"Alexander LJ. Retina. Optom Vis Sci. 2013, 90:305. 10.1097\/opx.0000000000000118","journal-title":"Optom Vis Sci"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(90)32506-X","article-title":"Scleral buckling in stages 4b and 5 retinopathy of prematurity","volume":"97","author":"Greven C","year":"1990","unstructured":"Greven C, Tasman W. Scleral buckling in stages 4b and 5 retinopathy of prematurity. Ophthalmology. 1990, 97:817-20. 10.1016\/S0161-6420(90)32506-X","journal-title":"Ophthalmology"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1080\/17469899.2019.1596026","article-title":"A review of treatment for retinopathy of prematurity","volume":"14","author":"Hansen ED","year":"2019","unstructured":"Hansen ED, Hartnett ME. A review of treatment for retinopathy of prematurity. Expert Rev Ophthalmol. 2019, 14:73-87. 10.1080\/17469899.2019.1596026","journal-title":"Expert Rev Ophthalmol"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(01)00809-0","article-title":"Lens-sparing vitreous surgery for tractional stage 4A retinopathy of prematurity retinal detachments","volume":"108","author":"Capone A","year":"2001","unstructured":"Capone A, Trese MT. Lens-sparing vitreous surgery for tractional stage 4A retinopathy of prematurity retinal detachments. Ophthalmology. 2001, 108:2068-70. 10.1016\/S0161-6420(01)00809-0","journal-title":"Ophthalmology"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2016-309198","article-title":"Long-term functional results following vitrectomy for advanced retinopathy of prematurity","volume":"101","author":"Karacorlu M","year":"2017","unstructured":"Karacorlu M, Hocaoglu M, Sayman Muslubas I, Arf S. Long-term functional results following vitrectomy for advanced retinopathy of prematurity. Br J Ophthalmol. 2017, 101:730-4. 10.1136\/bjophthalmol-2016-309198","journal-title":"Br J Ophthalmol"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000000771","article-title":"A randomized, placebo-controlled study of intravitreal ocriplasmin in pediatric patients scheduled for vitrectomy","volume":"36","author":"Drenser K","year":"2016","unstructured":"Drenser K, Girach A, Capone A Jr. A randomized, placebo-controlled study of intravitreal ocriplasmin in pediatric patients scheduled for vitrectomy. Retina. 2016, 36:565-75. 10.1097\/IAE.0000000000000771","journal-title":"Retina"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6702642","article-title":"Sub-Tenon's local anaesthesia for the treatment of retinopathy of prematurity with diode laser","volume":"22","author":"Parulekar MV","year":"2008","unstructured":"Parulekar MV, Chen SD, Patel CK. Sub-Tenon's local anaesthesia for the treatment of retinopathy of prematurity with diode laser. Eye (Lond). 2008, 22:375-9. 10.1038\/sj.eye.6702642","journal-title":"Eye (Lond)"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.86305","article-title":"Use of intravitreal anti-VEGF: retinopathy of prematurity surgeons' in Hamlet's dilemma?","volume":"59","author":"Azad R","year":"2011","unstructured":"Azad R, Dave V, Jalali S. Use of intravitreal anti-VEGF: retinopathy of prematurity surgeons' in Hamlet's dilemma?. Indian J Ophthalmol. 2011, 59:421-2. 10.4103\/0301-4738.86305","journal-title":"Indian J Ophthalmol"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1053\/j.semperi.2019.05.004","article-title":"Primary prevention of ROP and the oxygen saturation targeting trials","volume":"43","author":"Darlow BA","year":"2019","unstructured":"Darlow BA, Husain S. Primary prevention of ROP and the oxygen saturation targeting trials. Semin Perinatol. 2019, 43:333-40. 10.1053\/j.semperi.2019.05.004","journal-title":"Semin Perinatol"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1039","article-title":"Exposure to any antenatal corticosteroids and outcomes in preterm infants by gestational age: prospective cohort study","volume":"356","author":"Travers CP","year":"2017","unstructured":"Travers CP, Clark RH, Spitzer AR, Das A, Garite TJ, Carlo WA. Exposure to any antenatal corticosteroids and outcomes in preterm infants by gestational age: prospective cohort study. BMJ. 2017, 356:j1039. 10.1136\/bmj.j1039","journal-title":"BMJ"},{"key":"ref87","article-title":"Preventing sight-threatening ROP: a neonatologist\u2019s perspective","volume":"30","author":"Deorari A","year":"2017","unstructured":"Deorari A, Darlow BA. Preventing sight-threatening ROP: a neonatologist\u2019s perspective. Community Eye Heal. 2017, 30:50-2.","journal-title":"Community Eye Heal"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.15761\/pd.1000120","article-title":"Oxygen saturations in premature infants at resuscitation. Where is the evidence?","volume":"1","author":"Kumar VHS","year":"2016","unstructured":"Kumar VHS. Oxygen saturations in premature infants at resuscitation. Where is the evidence?. Pediatr Dimens. 2016, 1:120. 10.15761\/pd.1000120","journal-title":"Pediatr Dimens"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-0978","article-title":"Resuscitation of preterm neonates with limited versus high oxygen strategy","volume":"132","author":"Kapadia VS","year":"2013","unstructured":"Kapadia VS, Chalak LF, Sparks JE, Allen JR, Savani RC, Wyckoff MH. Resuscitation of preterm neonates with limited versus high oxygen strategy. Pediatrics. 2013, 132:e1488-96. 10.1542\/peds.2013-0978","journal-title":"Pediatrics"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1053\/j.semperi.2015.12.006","article-title":"Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity","volume":"40","author":"Beharry KD","year":"2016","unstructured":"Beharry KD, Valencia GB, Lazzaro DR, Aranda JV. Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity. Semin Perinatol. 2016, 40:189-202. 10.1053\/j.semperi.2015.12.006","journal-title":"Semin Perinatol"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.2147\/EB.S99038","article-title":"Retinopathy of prematurity: the need for prevention","volume":"8","author":"Liegl R","year":"2016","unstructured":"Liegl R, Hellstr\u00f6m A, Smith LE. Retinopathy of prematurity: the need for prevention. Eye Brain. 2016, 8:91-102. 10.2147\/EB.S99038","journal-title":"Eye Brain"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1093\/pch\/21.2.101","article-title":"Retinopathy of prematurity: an update on screening and management","volume":"21","author":"Jefferies AL","year":"2016","unstructured":"Jefferies AL. Retinopathy of prematurity: an update on screening and management. Paediatr Child Health. 2016, 21:101-8. 10.1093\/pch\/21.2.101","journal-title":"Paediatr Child Health"},{"key":"ref93","article-title":"Role of neonatal team including nurses in prevention of ROP","volume":"31","author":"Murki S","year":"2018","unstructured":"Murki S, Kadam S. Role of neonatal team including nurses in prevention of ROP. Community Eye Health. 2018, 31:S11-5.","journal-title":"Community Eye Health"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2015-308704","article-title":"Potential for a paradigm change in the detection of retinopathy of prematurity requiring treatment","volume":"101","author":"Gilbert C","year":"2016","unstructured":"Gilbert C, Wormald R, Fielder A, et al.. Potential for a paradigm change in the detection of retinopathy of prematurity requiring treatment. Arch Dis Child Fetal Neonatal Ed. 2016, 101:F6-9. 10.1136\/archdischild-2015-308704","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-0378","article-title":"Neonatologists' practices and experiences in arranging retinopathy of prematurity screening services","volume":"120","author":"Kemper AR","year":"2007","unstructured":"Kemper AR, Wallace DK. Neonatologists' practices and experiences in arranging retinopathy of prematurity screening services. Pediatrics. 2007, 120:527-31. 10.1542\/peds.2007-0378","journal-title":"Pediatrics"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.4103\/jcn.jcn_102_18","article-title":"Management of retinopathy of prematurity in a neonatal unit: current approach","volume":"8","author":"Parappil H","year":"2019","unstructured":"Parappil H, Pai A, Mahmoud N, AlKhateeb M, Al Rifai H, El Shafei M. Management of retinopathy of prematurity in a neonatal unit: current approach. J Clin Neonatol. 2019, 8:203. 10.4103\/jcn.jcn_102_18","journal-title":"J Clin Neonatol"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0000000000000471","article-title":"Top five legal pitfalls in retinopathy of prematurity","volume":"29","author":"Moshfeghi DM","year":"2018","unstructured":"Moshfeghi DM. Top five legal pitfalls in retinopathy of prematurity. Curr Opin Ophthalmol. 2018, 29:206-9. 10.1097\/ICU.0000000000000471","journal-title":"Curr Opin Ophthalmol"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1067\/mpa.2000.106203","article-title":"Compliance with outpatient follow-up recommendations for infants at risk for retinopathy of prematurity","volume":"4","author":"Aprahamian AD","year":"2000","unstructured":"Aprahamian AD, Coats DK, Paysse EA, Brady-Mccreery K. Compliance with outpatient follow-up recommendations for infants at risk for retinopathy of prematurity. J AAPOS. 2000, 4:282-6. 10.1067\/mpa.2000.106203","journal-title":"J AAPOS"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.22608\/APO.2017478","article-title":"Telemedicine for ROP","volume":"7","author":"Shah PK","year":"2018","unstructured":"Shah PK, Ramya A, Narendran V. Telemedicine for ROP. Asia Pac J Ophthalmol (Phila). 2018, 7:52-5. 10.22608\/APO.2017478","journal-title":"Asia Pac J Ophthalmol (Phila)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/420197-management-of-retinopathy-of-prematurity-in-the-united-arab-emirates-a-consensus-statement-from-the-emirates-society-of-ophthalmology","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T14:40:19Z","timestamp":1770388819000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/420197-management-of-retinopathy-of-prematurity-in-the-united-arab-emirates-a-consensus-statement-from-the-emirates-society-of-ophthalmology"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":99,"URL":"https:\/\/doi.org\/10.7759\/cureus.103096","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,6]]}}}